Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ghrelin increases food intake in obese as well as lean subjects.
Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C, Bloom SR. Druce MR, et al. Among authors: park aj. Int J Obes (Lond). 2005 Sep;29(9):1130-6. doi: 10.1038/sj.ijo.0803001. Int J Obes (Lond). 2005. PMID: 15917842 Clinical Trial.
Pancreatic polypeptide reduces appetite and food intake in humans.
Batterham RL, Le Roux CW, Cohen MA, Park AJ, Ellis SM, Patterson M, Frost GS, Ghatei MA, Bloom SR. Batterham RL, et al. Among authors: park aj. J Clin Endocrinol Metab. 2003 Aug;88(8):3989-92. doi: 10.1210/jc.2003-030630. J Clin Endocrinol Metab. 2003. PMID: 12915697 Clinical Trial.
Oxyntomodulin suppresses appetite and reduces food intake in humans.
Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, Frost GS, Ghatei MA, Bloom SR. Cohen MA, et al. J Clin Endocrinol Metab. 2003 Oct;88(10):4696-701. doi: 10.1210/jc.2003-030421. J Clin Endocrinol Metab. 2003. PMID: 14557443 Clinical Trial.
Neuroendocrine control of food intake.
Park AJ, Bloom SR. Park AJ, et al. Curr Opin Gastroenterol. 2005 Mar;21(2):228-33. doi: 10.1097/01.mog.0000153358.05901.3f. Curr Opin Gastroenterol. 2005. PMID: 15711218 Review.
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, Frost GS, Ghatei MA, Bloom SR. Neary NM, et al. Among authors: park aj. Endocrinology. 2005 Dec;146(12):5120-7. doi: 10.1210/en.2005-0237. Epub 2005 Sep 8. Endocrinology. 2005. PMID: 16150917 Clinical Trial.
Low-dose pancreatic polypeptide inhibits food intake in man.
Jesudason DR, Monteiro MP, McGowan BM, Neary NM, Park AJ, Philippou E, Small CJ, Frost GS, Ghatei MA, Bloom SR. Jesudason DR, et al. Among authors: park aj. Br J Nutr. 2007 Mar;97(3):426-9. doi: 10.1017/S0007114507336799. Br J Nutr. 2007. PMID: 17313701 Clinical Trial.
Peptides and obesity: the PYY3-36 story.
Park A, Bloom SR. Park A, et al. Regul Pept. 2004 Jun 15;119(1-2):1-2. doi: 10.1016/j.regpep.2004.02.006. Regul Pept. 2004. PMID: 15093690 No abstract available.
208 results